Fundprints logofundprints
Log inGet started

The Fund Grade · free · no account needed

What grade does NMVLX get?

Morningstar rates funds on what they returned. We grade them on where their money sits today: how much of the book overlaps with the converged buys of the top specialist stock pickers.

B

Fundprints Fund Grade · as of 2026-09-01

Nuance Mid Cap Value Fund

#189 of 440 graded active funds · value · mid segment peer group

The point · specialist footprint

NMVLX puts less of its book behind proven specialists than 75% of graded funds.

Bottom 20%

● Bottom 40%

Middle

Top 40%

Top 20%

beat the S&P in 22% of quarters+3.8 pts/qtr better · 43% beat rate

That has mattered: over the past 2.7 years, funds with this little specialist backing trailed top-rung funds by about 3.8 points per quarter and beat the S&P in only 22% of fund-quarters. If it also charges an active fee, the higher-graded alternatives deserve a look.

2,825 graded funds · 2.7 years of filings, measured as they were published · evidence, not advice

The grade scores this fund's specialist share — the slice that overlaps what the top 1% of proven funds are building. We ignore index ballast and names outside our edge on purpose: that slice is small, and it's what decides the outcome.

Conviction exposure

3.9%

of the book in specialist-converged names

Late-stage weight

8.3%

of the book in Crowded or Fading names

Active share

97.8%

how far it strays from the index

The best grades have beaten the worst by about +5% a year since we began grading. The gap held in 9 out of 10 months. Measured on filings as they were published, no hindsight.

Inside the book — top names by stage · as of 2026-09-09

Early Conviction
KVUE 3.1%DOC 0.8%
Consensus
CWT 6.5%WERN 4.6%SOLV 4.5%+18 locked
Emerging
ACN 0.5%ABT 0.5%NOC 0.3%+1 locked
Crowded
KMB 2.9%AVO 0.5%GGG 0.2%
Fading
CLX 4.8%ATR 2.2%AVA 1.5%+4 locked
see the names driving this grade, and how early each one is →
Watch this fund — free →X-ray what's inside →

We email you the day it crosses 50% crowded, and where you stand every month.

Graded monthly from point-in-time filings. A description of where the money sits, not a recommendation. Evidence, not advice.

The read · what to do with it

Support leaving these positions

CLX 4.8% of the fund · Fading

KMB 2.9% of the fund · Crowded

ATR 2.2% of the fund · Fading

AVA 1.5% of the fund · Fading

NKE 1.3% of the fund · Fading

Where it's genuinely early

KVUE 3.1% of the fund · Early Conviction

DOC 0.8% of the fund · Early Conviction

ACN 0.5% of the fund · Emerging

Read from today's disclosed book. Evidence, not advice.

The evidence base updates this week.

The specialists — not the whales — are already positioned for what comes next. Stop finding out last.

Create your free account

No card required · open the feed in 30 seconds